- Home
- NLY vs SNN Comparison
NLY vs SNN Comparison
Compare NLY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NLY | SNN |
|---|---|---|
| Founded | 1996 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 14.0B |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | NLY | SNN |
|---|---|---|
| Price | $22.79 | $32.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $21.63 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 7.0M | 491.8K |
| Earning Date | 01-28-2026 | 03-02-2026 |
| Dividend Yield | ★ 12.39% | 2.24% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 2.19 | 0.56 |
| Revenue | $1,748,174,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $358.71 | $7.78 |
| Revenue Next Year | $8.02 | $5.13 |
| P/E Ratio | ★ $10.30 | $28.52 |
| Revenue Growth | ★ 275.23 | 5.35 |
| 52 Week Low | $16.60 | $23.69 |
| 52 Week High | $22.98 | $38.79 |
Technical Indicators
Market Signals| Indicator | NLY | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 47.45 |
| Support Level | $22.10 | $32.06 |
| Resistance Level | $22.52 | $33.60 |
| Average True Range (ATR) | 0.29 | 0.42 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 78.86 | 48.38 |
Price Performance
Historical ComparisonAbout NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.